Copy For Citation
Kayı Cangır A.
JOURNAL OF THORACIC ONCOLOGY, vol.19, no.5, pp.766-785, 2024 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
19
Issue:
5
-
Publication Date:
2024
-
Doi Number:
10.1016/j.jtho.2023.10.012
-
Journal Name:
JOURNAL OF THORACIC ONCOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
-
Page Numbers:
pp.766-785
-
Ankara University Affiliated:
Yes
Abstract
The accurate assessment of nodal (N) status is crucial to the management and prognostication of nonmetastatic NSCLC. We sought to determine whether the current N descriptors should be maintained or revised for the upcoming ninth edition of the international TNM lung cancer staging system.
Methods
Data were assembled by the International Association for the Study of Lung Cancer on patients with NSCLC, detailing both clinical and pathologic N status, with information about anatomical location and individual station-level identification. Survival was calculated by the Kaplan-Meier method and prognostic groups were assessed by a Cox regression analysis.
Results
Data for clinical N and pathologic N status were available in 45,032 and 35,009 patients, respectively. The current N0 to N3 descriptors for both clinical N and pathologic N categories reflect prognostically distinct groups. Furthermore, single-station N2 involvement (N2a) exhibited a better prognosis than multistation N2 involvement (N2b) in both clinical and pathologic classifications, and the differences between all neighboring nodal subcategories were highly significant. The prognostic differences between N2a and N2b were robust and consistent across resection status, histologic type, T category, and geographic region.
Conclusions
The current N descriptors should be maintained, with the addition of new subdescriptors to N2 for single-station involvement (N2a) and multiple-station involvement (N2b).